In a landmark move, China has scrapped the 30% import duty on Indian pharmaceutical products, allowing duty-free exports and opening up one of the world's largest healthcare markets to Indian drug makers. The decision comes as the US imposes steep tariffs, offering India a crucial alternative market that could boost exports, create jobs, and strengthen global supply chain presence.